01 1Sun Pharmaceutical Industries Limited
01 1TOPIRAMATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-09-25
Pay. Date : 2023-09-20
DMF Number : 18172
Submission : 2005-03-04
Status : Active
Type : II
20
Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TOPIRAMATE USP, with a corresponding US DMF Number 18172.
Remarkably, this DMF maintains an Active status since its submission on March 04, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 25, 2023, and payment made on September 20, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
